Predictive Factors for Long-term Clinical Outcomes in Patients with Variant Angina

Choi, Myung Ja; Jeong, Myung Ho; Cho, Jae Yeong; Lee, Young Sook; Rhee, Jung Ae; Choi, Jin Su; Sim, Doo Sun; Park, Keun Ho; Hong, Young Joon; Kim, Ju Han; Ahn, Young Keun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee

doi:10.3904/kjm.2013.84.4.522

Cited by 3 publications

(3 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, the extent of surgical resection may be reduced for GGO lesions. For example, a number of studies have reported good prognosis when sublobar resection is applied to peripheral pure GGO or part-solid GGO (24)(25)(26). We have also reported that the prognosis after limited resection is fairly good even if the lesion presenting as GGO on chest CT is diagnosed as invasive adenocarcinoma postoperatively (19).…”

Section: Discussionmentioning

confidence: 99%

Predictive factors for invasive adenocarcinoma in patients with clinical non-invasive or minimally invasive lung cancer

et al. 2018

View full text Add to dashboard Cite

Background: Pure ground glass opacity (GGO) or part-solid GGO with small solid component (≤5 mm) are likely to be non-invasive or minimally invasive lung cancer. However, those lesions sometimes are diagnosed as invasive adenocarcinoma postoperatively. The aim of this study was to determine the predictors of invasive adenocarcinoma in clinical non-or minimally invasive lung cancer. Methods: From January 2010 to December 2017, 203 patients were diagnosed as clinical adenocarcinoma in situ (AIS) or minimally invasive adenocarcinoma (MIA) identified on chest computed tomography (CT) and they underwent surgical resection. A retrospective study was performed to analyze the prediction of invasive adenocarcinoma in clinical non-or minimally invasive lung cancer. Results: Of all clinical AIS or MIA patients, invasive adenocarcinoma was diagnosed in 55 patients (27.1%).In clinical AIS, invasive adenocarcinoma was diagnosed in 19 patients (17.9%) and 36 patients (37.1%) were diagnosed as invasive adenocarcinoma in clinical MIA (P=0.002). Tumor diameter and the presence of solid component were confirmed to be significant predictive factors for invasive adenocarcinoma in a multivariate analysis [hazard ratio (HR) 1.071, P=0.037; HR 2.573, P=0.005; respectively]. Conclusions: Large tumor size and the presence of solid component in clinical AIS or MIA are predictive factors for invasive adenocarcinoma. Therefore, early surgical intervention is recommended for those lesions.

show abstract

Section: Discussionmentioning

confidence: 99%

Predictive factors for invasive adenocarcinoma in patients with clinical non-invasive or minimally invasive lung cancer

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Patients who continued to smoke showed a stronger tendency for lower compliance with self-care and lifestyle modification. Choi et al 20) reported predictive factors for long-term clinical outcomes in 1162 patients with variant angina between 1996 and 2011. A history of smoking was the only independent risk factor for MACEs during long-term clinical follow-up in Korean patents with variant angina.…”

Section: Discussionmentioning

confidence: 99%

Impact of Smoking on Clinical Outcomes in Female Patients with Acute Myocardial Infarction

Jeong

et al. 2015

Korean Circ J

Self Cite

View full text Add to dashboard Cite

Background and ObjectivesCigarette smoking has been recognized as a prominent threat to women's health. We investigated the impact of smoking on clinical outcomes in Korean female patients after acute myocardial infarction (AMI).Subjects and MethodsOut of the AMI patients who enrolled in the Korea AMI Registry, 4444 female patients were included in this study. Patients were divided into two groups-non-smoker and smoker-according to their current smoking status. We compared in-hospital mortality and major adverse cardiac events (MACE), including cardiac death, myocardial infarction, repeated percutaneous coronary intervention (PCI), or coronary artery bypass grafting during the one-year clinical follow-up period between two groups.ResultsThe non-smoker group had more hypertension (HTN) and diabetes mellitus. The levels of total cholesterol, triglyceride, and low-density lipoprotein cholesterol were higher in the non-smoker group. However, in-hospital mortality was significantly higher in the smoker group (1.0% vs. 2.4%, p=0.002), and cardiac death during the 12-month clinical follow-up was significantly more frequent in the smoker group (2.2% vs. 4.5%, p=0.003). Total MACEs during the 12 months were higher in the smoker group (4.9% vs. 6.8%, p=0.014). Smoking and HTN were independent predictors of MACE {odds ratio (OR): 1.742, 95% confidence interval (CI): 1.010-3.000, p=0.046; OR: 1.573, 95% CI: 1.003-2.466, p=0.049, respectively}.ConclusionFemale smokers with AMI showed significantly higher in-hospital mortality and MACE rates during the one-year clinical follow-up period.

show abstract

“…According to the guidelines of the Japanese Society of Cardiology (JCS), the coronary spasm provocation test is the standard diagnostic method [5,6]. The relative prevalence of VA is unclear between Eastern and Western countries, although there is a higher incidence in Korea and Japan [7,8].…”

Section: Introductionmentioning

confidence: 99%

Comparison of clinical outcomes in patients with mixed angina and pure vasospastic angina

Song,

Kim,

Lee

2024

Coronary Artery Disease

View full text Add to dashboard Cite

Objective This study investigated differences in clinical outcomes between mixed angina (MA) and pure vasospastic angina (PVA). Methods A total of 524 vasospastic angina patients who did or did not have >50% coronary artery stenosis from January 2005 to January 2021 were divided into two groups (Group 1: PVA, N = 399; Group 2: MA, N = 125) and then three groups [Group 1: PVA, N = 399; Group 2: MA without percutaneous coronary intervention (PCI), N = 67; Group 3: MA with PCI, N = 58] for assessment. We recorded the incidence of major adverse cardiac and cerebrovascular events (MACCE: the composite of death, myocardial infarction, nonfatal stroke or rehospitalization) during 3-year clinical follow-up. Results Compared to the PVA group, there were significant differences in MACCE (20.8% vs. 11.8%, P = 0.011) and rehospitalization (20.0% vs. 9.8%, P = 0.002) in the MA group. Kaplan–Meier analysis showed that patients in the MA with PCI group had the highest cumulative incidence rate of MACCE during the 3-year follow-up (log-rank P < 0.001). Conclusion Compared with the PVA patients, MA patients had significantly worse clinical outcomes during long-term follow-up.

show abstract

Predictive Factors for Long-term Clinical Outcomes in Patients with Variant Angina

Cited by 3 publications

References 26 publications

Predictive factors for invasive adenocarcinoma in patients with clinical non-invasive or minimally invasive lung cancer

Predictive factors for invasive adenocarcinoma in patients with clinical non-invasive or minimally invasive lung cancer

Impact of Smoking on Clinical Outcomes in Female Patients with Acute Myocardial Infarction

Comparison of clinical outcomes in patients with mixed angina and pure vasospastic angina

Contact Info

Product

Resources

About